Middle East & Africa Dementia Treatment Market Size & Outlook

The dementia treatment market in Middle East & Africa is expected to reach a projected revenue of US$ 794.1 million by 2030. A compound annual growth rate of 7.6% is expected of Middle East & Africa dementia treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$474.3
Forecast, 2030 (US$M)
$794.1
CAGR, 2024 - 2030
7.6%
Report Coverage
Middle East & Africa

MEA dementia treatment market highlights

  • The MEA dementia treatment market generated a revenue of USD 474.3 million in 2023.
  • The market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
  • In terms of segment, alzheimer’s disease dementia was the largest revenue generating indication in 2023.
  • Lewy Body Dementia is the most lucrative indication segment registering the fastest growth during the forecast period.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 474.3 million
Market revenue in 2030USD 794.1 million
Growth rate7.6% (CAGR from 2023 to 2030)
Largest segmentAlzheimer’s disease dementia
Fastest growing segmentLewy Body Dementia
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAlzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia, Other Indications
Key market players worldwideEisai Co Ltd, Eli Lilly and Co, Novartis AG ADR, Daiichi Sankyo Co Ltd, AbbVie Inc, H. Lundbeck AS Class A, Biogen Inc, Cipla Ltd DR, Sun Pharmaceutical Industries, Viatris Inc


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.8% of the global dementia treatment market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,990.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dementia Treatment Market Scope

Dementia treatment market segmentation & scope
Alzheimer’s Disease Dementia
Vascular Dementia
Lewy Body Dementia
Frontotemporal Dementia (FTD)
Parkinson Disease Dementia
Other Indications
Cholinesterase Inhibitors
NMDA Receptor Antagonist
MAO Inhibitors
Combination Drug
Other Drug Classes
Oral
Transdermal Patch
Injectable
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Dementia Treatment Market Companies

Name Profile # Employees HQ Website

Middle East & Africa dementia treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dementia treatment market will help companies and investors design strategic landscapes.


Alzheimer’s disease dementia was the largest segment with a revenue share of 60.11% in 2023. Horizon Databook has segmented the Middle East & Africa dementia treatment market based on alzheimer’s disease dementia, vascular dementia, lewy body dementia, frontotemporal dementia (ftd), parkinson disease dementia, other indications covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Middle East & Africa dementia treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa dementia treatment market databook

  • Our clientele includes a mix of dementia treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa dementia treatment market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa dementia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA dementia treatment market report size, by country, 2018-2030 (US$M)

Middle East & Africa Dementia Treatment Market Share, 2023 & 2030 (US$M)

MEA dementia treatment market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more